首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in oncology

缩写:FRONT ONCOL

ISSN:2234-943X

e-ISSN:2234-943X

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引33243
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Min Ding,Tianrui He,Jing Yu et al. Min Ding et al.
Background: Predicting the intracranial efficacy of programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors in non-small cell lung cancer (NSCLC) patients with brain metastasis (BM) remains challenging. The o...
Huilai Lv,Bisong Chen,Chunyue Gai et al. Huilai Lv et al.
Background: Neoadjuvant immunochemotherapy has shown remarkable efficacy in locally advanced ESCC. Therapy cycles and interval to surgery impact treatment efficacy. However, no consensus exists on the optimal cycles or su...
Yuan Yuan,Qiang Tong,Jia-Hui Liu et al. Yuan Yuan et al.
Objective: This study aims to evaluate the efficacy and safety of hetrombopag in the management of chemotherapy-induced thrombocytopenia (CIT) among patients with solid tumors, utilizing a retrospective cohort study desig...
Xiaoqing Wang,Jingchuan Yu,Shuhan Xie et al. Xiaoqing Wang et al.
Introduction: The comprehensive complication index (CCI) is a valuable index to comprehensively and systematically evaluate complication severity. This study aimed to evaluate the predictive ability of comprehensive compl...
Chaoyang Zhang,Wei Hao Chaoyang Zhang
Background: To develop a model based on computed tomography (CT) images to differentiate between grade 3 (G3) pancreatic neuroendocrine tumors (pNETs) and pancreatic neuroendocrine carcinoma (pNECs). ...
Enrica Teresa Tanda,Agostina Lagodin D&#x;Amato,Giovanni Rossi et al. Enrica Teresa Tanda et al.
Immune checkpoint inhibitors (ICIs) have dramatically reshaped the therapeutic landscape of oncology, offering long-term survival benefits across multiple tumor types. However, ICIs are associated with a broad range of immune-related advers...
Nessma M Shahin,Mahmoud Hammad,Hanafy Hafez et al. Nessma M Shahin et al.
Background: Pediatric acute myeloid leukemia (AML) accounts for approximately 25% of childhood hematologic malignancies. Outcomes have markedly improved, especially in low-risk and intermediate-risk patients, with overall...
Qingqing Cai,Leqing Zhu,Quanwei Guo et al. Qingqing Cai et al.
Castleman's disease (CD) is a rare, benign lymphoproliferative disorder of unknown aetiology. CD occurring in the oesophageal region is exceedingly rare and may be misdiagnosed as oesophageal carcinoma or lymphoma, thus posing challenges fo...
Chuansheng Yang,Deping Luo,Jian Xie et al. Chuansheng Yang et al.
Background: The clinical utility of postoperative radioiodine therapy in patients with low-risk differentiated thyroid cancer (DTC) remains a subject of ongoing debate. Although radioiodine has been widely employed to red...
Bailin Wang,Long Liu,Meiqi Cui et al. Bailin Wang et al.
Background: Carcinoembryonic antigen (CEA) is still the most valuable tumor marker in the diagnosis and prognosis of non-small cell lung cancer (NSCLC) patients; however, its application is largely limited by its low sens...